ArticleBMC bioinformatics2005
A stepwise framework for the normalization of array CGH data.
Article in BMC bioinformatics, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed.
- Identifying crossovers and shared genetic material in whole genome sequencing data from families.Genome research · 2023Article
- Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes.Oncotarget · 2018Article
- Article
- NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer.Oncotarget · 2014Article
- Recurring DNA copy number gain at chromosome 9p13 plays a role in the activation of multiple candidate oncogenes in progressing oral premalignant lesions.Cancer medicine · 2014Article
- SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/β-catenin signaling.Oncogene · 2014Article
- YEATS4 is a novel oncogene amplified in non-small cell lung cancer that regulates the p53 pathway.Cancer research · 2013Article
- Evaluation of calling algorithms for array-CGH.Frontiers in genetics · 2013Article
- Reducing system noise in copy number data using principal components of self-self hybridizations.Proceedings of the National Academy of Sciences of the United States of America · 2012Article
- Article
- Identification of metastasis-associated breast cancer genes using a high-resolution whole genome profiling approach.Journal of cancer research and clinical oncology · 2011Article
- Cyclin E1 is amplified and overexpressed in osteosarcoma.The Journal of molecular diagnostics : JMD · 2011Article
- A new normalizing algorithm for BAC CGH arrays with quality control metrics.Journal of biomedicine & biotechnology · 2011Article
- Bayesian Random Segmentation Models to Identify Shared Copy Number Aberrations for Array CGH Data.Journal of the American Statistical Association · 2010Article
- Arsenic-related DNA copy-number alterations in lung squamous cell carcinomas.British journal of cancer · 2010Article
- Integrative molecular characterization of head and neck cancer cell model genomes.Head & neck · 2010Article
- Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.PLoS medicine · 2010Article
- An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer.BMC systems biology · 2010Article
- A critical assessment of cross-species detection of gene duplicates using comparative genomic hybridization.BMC genomics · 2010Article
- Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.PloS one · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundIn two-channel competitive genomic hybridization microarray experiments, the ratio of the two fluorescent signal intensities at each spot on the microarray is commonly used to infer the relative amounts of the test and reference sample DNA levels. This ratio may be influenced by systematic measurement effects from non-biological sources that can introduce biases in the estimated ratios. These biases should be removed before drawing conclusions about the relative levels of DNA. The performance of existing gene expression microarray normalization strategies has not been evaluated for removing systematic biases encountered in array-based comparative genomic hybridization (CGH), which aims to detect single copy gains and losses typically in samples with heterogeneous cell populations resulting in only slight shifts in signal ratios. The purpose of this work is to establish a framework for correcting the systematic sources of variation in high density CGH array images, while maintaining the true biological variations.
resultsAfter an investigation of the systematic variations in the data from two array CGH platforms, SMRT (Sub Mega base Resolution Tiling) BAC arrays and cDNA arrays of Pollack et al., we have developed a stepwise normalization framework integrating novel and existing normalization methods in order to reduce intensity, spatial, plate and background biases. We used stringent measures to quantify the performance of this stepwise normalization using data derived from 5 sets of experiments representing self-self hybridizations, replicated experiments, detection of single copy changes, array CGH experiments which mimic cell population heterogeneity, and array CGH experiments simulating different levels of gene amplifications and deletions. Our results demonstrate that the three-step normalization procedure provides significant improvement in the sensitivity of detection of single copy changes compared to conventional single step normalization approaches in both SMRT BAC array and cDNA array platforms.
conclusionThe proposed stepwise normalization framework preserves the minute copy number changes while removing the observed systematic biases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.